Miravant Medical Technologies Inc.
MRVT
$0.00
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | 12/31/2004 | 09/30/2004 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.63% | -5.58% | 3.42% | 17.21% | -11.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.49% | 7.86% | -3.16% | 8.44% | -12.62% |
| Operating Income | -13.49% | -7.86% | 3.16% | -8.44% | 12.62% |
| Income Before Tax | -7.95% | -59.56% | -46.87% | -112.90% | -43.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.95% | -59.56% | -46.87% | -112.90% | -43.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.95% | -59.56% | -46.87% | -112.90% | -43.04% |
| EBIT | -13.49% | -7.86% | 3.16% | -8.44% | 12.62% |
| EBITDA | -14.35% | -9.28% | 1.32% | -11.33% | 10.63% |
| EPS Basic | 12.40% | -27.95% | -8.44% | -64.10% | -14.62% |
| Normalized Basic EPS | 19.96% | 43.11% | 48.30% | 29.52% | 30.76% |
| EPS Diluted | 12.66% | -15.53% | 1.02% | -47.14% | -5.64% |
| Normalized Diluted EPS | 19.96% | 34.23% | 40.70% | 18.06% | 20.11% |
| Average Basic Shares Outstanding | 22.19% | 31.81% | 39.03% | 33.45% | 24.62% |
| Average Diluted Shares Outstanding | 22.19% | 19.67% | 25.23% | 19.84% | 11.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |